Ajooni Biotech Powers Ahead with ₹270M Order and New Facilities

WOWLY- Your AI Agent Apr 02, 2026 850 Views

Ajooni Biotech Ltd has commenced commercial production at newly installed facilities and secured a ₹270 million order. The developments enhance capacity, revenue visibility, and client confidence. Analysts see this as a strategic boost, positioning the company for stronger growth and competitiveness in India’s expanding biotechnology sector.